Bernard J. Uitdehaag
Amsterdam, NH, Netherlands
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 242 publications
The value of brain age as a transdiagnostic biomarker of neurodegeneration.
Journal: medRxiv : the preprint server for health sciences
Published: August 01, 2026
Treatment satisfaction during personalized extended interval dosing of natalizumab in patients with multiple sclerosis.
Journal: Multiple sclerosis and related disorders
Published: April 30, 2026
What if it is the eyes? The effect of eye movement disorders on cognitive testing in MS.
Journal: Journal of neurology
Published: April 10, 2026
Individual Variability of CD19+ B-Cell Repopulation in People With Multiple Sclerosis Treated With Extended Interval Dosing of Ocrelizumab.
Journal: European journal of neurology
Published: March 19, 2026
Multiple Sclerosis-Specific Reference Curves for Brain Volumes to Explain Disease Severity.
Journal: Neurology
Published: January 30, 2026
The impact of Information processing speed on visuospatial memory encoding and retrieval in multiple sclerosis.
Journal: Journal of clinical and experimental neuropsychology
Published: January 30, 2026
Breaking the PROMISE: poor association between brain volume loss and clinical disability worsening over 2 years of follow-up in primary progressive multiple sclerosis.
Journal: Journal of neurology, neurosurgery, and psychiatry
Published: November 04, 2025
Digital monitoring of disease activity in relapsing-remitting multiple sclerosis.
Journal: Journal of neurology
Published: October 16, 2025
Brain atrophy rates vary with age in relapsing-remitting multiple sclerosis.
Journal: Journal of neurology, neurosurgery, and psychiatry
Published: October 06, 2025
Aging does not affect the relationship between OCT and clinical or MRI outcome measures.
Journal: Multiple sclerosis and related disorders
Published: September 10, 2025
Last Updated: 09/26/2026